Growth hormone releasing factor analogs
AssigneeRoche Vitamins Inc.
InventorsArthur Martin Felix, Edgar Philip Heimer
Life of this patent
Estimating the term…
Loading patent…
AssigneeRoche Vitamins Inc.
InventorsArthur Martin Felix, Edgar Philip Heimer
Estimating the term…
Novel growth hormone releasing factor analogs are presented having a sequence of from about twenty-nine (29) to about forty-four (44) amino acids (SEQ ID NO: 6) wherein Xaa at position 1 is His, 3-MeHis, desNH.sub.2 His, Tyr, or desNH.sub.2 Tyr; Xaa at position 2 is Val, Leu, lie, Ala, D-Ala, N-Methyl-D-Ala, Gly, NIe, or Nval; Xaa at position 8 is Gln, Ser, or Thr; Xaa at position 15 is Ala or Leu; Xaa at position 27 is Met, Nle or Leu; Xaa at position 28 is Ser or Asn; Xaa at position 29 is an amino acid residue sequence (SEQ ID NO: 7) or fragments thereof where the fragment is reduced in number by one to fifteen amino acid residues from the carboxyl-terminus, where the carboxyl terminus can be the free carboxylic acid or the corresponding amide, and the pharmaceutically acceptable acid or base addition salts thereof. The novel growth hormone releasing factor analogs demonstrate enhanced potency for the release of growth hormone, have enhanced enzymatic stability, improved half-life stability in aqueous solution, and can be administered to a subject having a deficiency of growth hormone or for improvement of growth performance in livestock and other warm blooded animals and in fish and other cold blooded marine animals.
A compound having a sequence of from about twenty-nine (29) to about forty-four (44) amino acids (SEQ ID NO:
A pharmaceutical composition for stimulating the release of growth hormone in warm or cold-blooded animals comprising a compound having a sequence of from about twenty-nine (29) to about forty-four (44) amino acids (SEQ ID NO:
A method of treating growth hormone related disorders characterized by growth hormone deficiencies or for improvement of growth performance in warm or cold-blooded animals comprising administering to said animal in need of such treatment a compound having a sequence of from about twenty-nine (29) to about forty-four (44) amino acids (SEQ ID NO:
Dependencies are inferred from the claim text.